Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/2012
06/13/2012CN102492022A Novel anti-senile dementia lead compound
06/13/2012CN101962401B Polypeptin and preparation and application thereof
06/13/2012CN101607983B Encephalitis B virus PrM/M protein B cell antigen epitope polypeptide and applications
06/12/2012US8198403 Diameter-selective reversible closable peptides
06/12/2012US8198401 Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritis
06/12/2012US8198400 Liposomal vaccines containing immunogenic lipopeptides from tuberculosis, malaria, and hepatitis B peptides
06/12/2012US8198240 Methods for treatment of headaches by administration of oxytocin
06/12/2012US8197824 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
06/12/2012US8197820 HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/12/2012US8197793 Methods of radiofluorination of biologically active vectors
06/12/2012CA2404325C Immunotherapeutic methods and compositions
06/12/2012CA2214830C Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
06/07/2012WO2012075243A2 Methods and compositions for targeting sites of neovascular growth
06/07/2012WO2012073459A1 Tomm34 peptides and vaccines including the same
06/07/2012WO2011060528A8 Heteropeptides useful for reducing nonspecific adsorption
06/07/2012US20120142894 Identification, Optimization and Use of Shared HLA-B*0702 Epitopes for Immunotherapy
06/07/2012US20120142893 Separation and/or purification of b0 from c0
06/07/2012US20120142892 Contoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
06/07/2012US20120142614 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
06/07/2012US20120142596 Agent for stimulating mobilization of endothelial progenitor cells
06/07/2012US20120142595 Tissue protective peptides and uses thereof
06/07/2012US20120142090 Protein Expression System
06/07/2012US20120141973 Perfusion and/or preservation solution for organs
06/07/2012US20120141788 Process and device for the precipitation of an organic compound
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
06/07/2012US20120141527 Structured viral peptide compositions and methods of use
06/07/2012US20120141517 Novel immunotherapy against several tumors including neuronal and brain tumors
06/07/2012US20120141516 Compositions and methods for inducing an immune response
06/07/2012US20120141499 Specific binding agents of human angiopoietin-2
06/07/2012US20120141487 Moraxella catarrhalis antigens
06/07/2012CA2819608A1 Novel cyclosporin derivatives for the treatment and prevention of a viral infection
06/07/2012CA2819463A1 Tomm34 peptides and vaccines including the same
06/06/2012EP2460815A1 Plant-derived elastin binding protein ligands and methods of using the same
06/06/2012EP2459584A1 Homing peptide for tumor vasculature
06/06/2012EP2459583A1 Peptide-polymer cell culture articles and methods of making
06/06/2012EP2459208A2 Therapeutic agents for reducing parathyroid hormone levels
06/06/2012EP2261374B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having Class I membrane fusogenic envelope proteins
06/06/2012EP1709075B1 Treatment of viral infections
06/06/2012CN1409725B Peptide minics of conserved gonococcal epitopes and methods and compositions using them
06/06/2012CN1367789B Synthesis of template-fixed beta-hairpin loop mimetics
06/06/2012CN102485748A Oligopeptides with targeting thrombolytic activity, preparation method thereof, and application thereof
06/06/2012CN102485747A Oligopeptides with targeting thrombolytic activity, preparation method and application thereof
06/06/2012CN102485746A Oligopeptides having target-oriented thrombolytic activity and their preparation method and application
06/06/2012CN102485745A Thrombolytic oligopeptides, preparation method and application thereof
06/06/2012CN102485744A Thrombolytic oligopeptide compound, its preparation method and application
06/06/2012CN101948514B Method for improving total component content of colistin sulphate
06/06/2012CN101863965B Helicobacter pylori urease B antigenic epitope polypeptide and application thereof
06/06/2012CN101446585B Reagent for detecting tubercle bacillus infection in vitro and method thereof
06/06/2012CN101190942B Compound with thrombus dissolving activity and its preparation method and application
06/06/2012CN101190940B Polypeptide with target antithrombotic activity and its preparation method and application
06/05/2012US8193310 Alpha helical mimics, their uses and methods for their production
06/05/2012CA2405183C Use of a rest of pya-(z)x-pnf for detection means, identification and/or dosage by use of a fluorescence detection of proteases or peptidases
06/05/2012CA2286575C Sustained-release compositions and method for preparing same
06/05/2012CA2248667C Hla-a2.1 binding peptides and their uses
05/2012
05/31/2012WO2012070936A1 Novel angiotensin type 2 (at2) receptor agonists and uses thereof
05/31/2012WO2012070554A1 Peptide
05/31/2012WO2012040259A3 Modified compstatin with improved stability and binding properties
05/31/2012WO2012034025A3 Human cytomegalovirus vaccine
05/31/2012WO2012033993A3 Methods for assaying enzyme activities
05/31/2012US20120136416 Caged Neuropeptides: modulation and measurement of synapse and signaling activity; and methods for drug evaluation, pharmaceuticals preparation and treatment
05/31/2012US20120135942 Beta-hairpin peptidomimetics
05/31/2012US20120135939 Cyclosporin Analogs
05/31/2012US20120135931 Method of modifying serine protease inhibitors
05/31/2012US20120135918 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
05/31/2012US20120135917 Anti-Gram Negative Bacteria Agent
05/31/2012US20120135914 Etoposide and doxorubicin conjugates for drug delivery
05/31/2012US20120135024 Neisseria meningitidis antigens and compositions
05/31/2012US20120135021 Cell penetrating peptides and its use fused to biomolecules with therapeutic action
05/31/2012US20120135020 Ttk peptides and vaccines including the same
05/31/2012US20120134991 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function
05/31/2012US20120134931 Peptides whose uptake in cells is controllable
05/31/2012US20120134930 Pyrazine Derivatives for Bioconjugation
05/31/2012US20120134923 Radioiodination method
05/31/2012US20120134922 Peptides whose uptake in cells is controllable
05/31/2012CA2818299A1 Novel angiotensin type 2 (at2) receptor agonists and uses thereof
05/30/2012EP2458380A2 Specific molecules clinging to a lure
05/30/2012EP2458379A2 Specific molecules clinging to a lure
05/30/2012EP2456910A1 Differentiation of isobaric amino acids and other species
05/30/2012EP2456784A1 Compounds modulators of vegf activity and uses thereof
05/30/2012EP2456459A1 Vaccine
05/30/2012EP1960422B1 Potent compstatin analogs
05/30/2012EP1176193B1 Inhibitors for viral infection targeting integrase n-terminal region
05/30/2012CN1985000B T-cell death-inducing epitopes
05/30/2012CN102482326A 分离治疗用肽的方法 Therapeutic peptides isolated
05/30/2012CN102482325A Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
05/30/2012CN102482324A Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
05/30/2012CN102482323A 新型肽及其应用 Novel peptide and its application
05/30/2012CN102481336A 从棘白菌素C<sub>0</sub>中分离和/或提纯棘白菌素B<sub>0</sub> From Echinocandin C <sub> 0 </ sub> separation and / or purification Echinocandin B <sub> 0 </ sub>
05/30/2012CN102477083A Carcinoembryonic antigen specific binding peptide with targeting therapy and low-toxic side effects
05/30/2012CN102477082A 一种液相合成法合成卡贝缩宫素的方法 One kind of liquid-phase synthesis method Carbetocin methods
05/30/2012CN102477081A 一种新型多肽在干燥综合征诊断中的应用 A novel peptide used in the diagnosis of Sjogren's syndrome
05/30/2012CN102477080A 一种新型多肽在类风湿关节炎诊断中的应用 A novel peptide used in the diagnosis of rheumatoid arthritis
05/30/2012CN102477079A 一种新型多肽在系统性红斑狼疮诊断中的应用 A novel peptide used in the diagnosis of systemic lupus erythematosus
05/30/2012CN102477078A 胸腺体液因子(THF)-γ2改构肽的制备及其药物组合物的用途 Preparation and use of pharmaceutical compositions thymic humoral factor (THF) -γ2 the altered peptide
05/30/2012CN102477077A Boc-Pro-Ala-Lys-Lys(Pro-Ala-Lys)-OCH<sub>2</sub>(CH<sub>2</sub>)nCH<sub>3</sub>、其合成和作为溶血栓剂的应用 Boc-Pro-Ala-Lys-Lys (Pro-Ala-Lys) -OCH <sub> 2 </ sub> (CH <sub> 2 </ sub>) nCH <sub> 3 </ sub>, its synthesis and As the application of thrombolytic agents
05/30/2012CN102477076A Oligopeptide compound for thrombolysis, its preparation method and application
05/30/2012CN102477075A 用于抗血栓的寡肽及其制备方法和应用 For antithrombotic oligopeptide and its preparation method and application
05/30/2012CN102477074A 寡肽化合物及其制备方法和应用 Oligopeptide compound and its preparation method and application
05/30/2012CN102477073A 具有溶血栓活性的寡肽及其制备方法和应用 Oligopeptide and its preparation method and application having thrombolytic activity
05/30/2012CN102477072A 用于溶血栓的寡肽化合物及其制备方法和应用 Compounds used in its preparation method and application of thrombolytic oligopeptide
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 423